BioCentury
ARTICLE | Clinical News

Bristol-Myers Squibb Co regulatory update

January 8, 1996 8:00 AM UTC

Bristol-Myers' ZERIT (stavudine, d4T) nucleoside analog received final FDA approval to treat HIV. The product is indicated to treat adults with HIV who have undergone prolonged treatment with AZT. ...